DK3144676T3 - Kit omfattende antistof der specifikt binder til komplementfaktor b protein og antistof der specifikt binder til kulhydratantigen 19-9 protein til diagnosticering af cancer i bugspytkirtlen - Google Patents

Kit omfattende antistof der specifikt binder til komplementfaktor b protein og antistof der specifikt binder til kulhydratantigen 19-9 protein til diagnosticering af cancer i bugspytkirtlen Download PDF

Info

Publication number
DK3144676T3
DK3144676T3 DK14892029.1T DK14892029T DK3144676T3 DK 3144676 T3 DK3144676 T3 DK 3144676T3 DK 14892029 T DK14892029 T DK 14892029T DK 3144676 T3 DK3144676 T3 DK 3144676T3
Authority
DK
Denmark
Prior art keywords
bines
protein
specifically
antibody
diagnostication
Prior art date
Application number
DK14892029.1T
Other languages
English (en)
Inventor
Young-Ki Paik
Min Jung Lee
Original Assignee
Jw Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54480106&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3144676(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jw Holdings Corp filed Critical Jw Holdings Corp
Application granted granted Critical
Publication of DK3144676T3 publication Critical patent/DK3144676T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Electrochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
DK14892029.1T 2014-05-12 2014-09-03 Kit omfattende antistof der specifikt binder til komplementfaktor b protein og antistof der specifikt binder til kulhydratantigen 19-9 protein til diagnosticering af cancer i bugspytkirtlen DK3144676T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140056585A KR20150129932A (ko) 2014-05-12 2014-05-12 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
PCT/KR2014/008242 WO2015174585A1 (ko) 2014-05-12 2014-09-03 보체인자 ｂ 단백질에 특이적으로 결합하는 항체 및 카보하이드레이트 안티젠 19-9 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트

Publications (1)

Publication Number Publication Date
DK3144676T3 true DK3144676T3 (da) 2020-03-16

Family

ID=54480106

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14892029.1T DK3144676T3 (da) 2014-05-12 2014-09-03 Kit omfattende antistof der specifikt binder til komplementfaktor b protein og antistof der specifikt binder til kulhydratantigen 19-9 protein til diagnosticering af cancer i bugspytkirtlen

Country Status (10)

Country Link
US (1) US10656154B2 (da)
EP (1) EP3144676B1 (da)
JP (1) JP6361943B2 (da)
KR (1) KR20150129932A (da)
CN (1) CN106461665B (da)
DK (1) DK3144676T3 (da)
ES (1) ES2776733T3 (da)
PL (1) PL3144676T3 (da)
PT (1) PT3144676T (da)
WO (1) WO2015174585A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2140269T3 (da) 2007-03-27 2013-12-16 Immunovia Ab Proteinsignatur/markører til at detektere adenocarcinom
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
KR102289278B1 (ko) * 2019-07-09 2021-08-13 주식회사 베르티스 췌장암 진단용 바이오마커 패널 및 그 용도
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63159763A (ja) * 1986-12-24 1988-07-02 Fujirebio Inc 逆受身凝集反応試薬
AU2003294828A1 (en) * 2002-12-17 2004-07-09 Sinogenomax Co. Ltd. Chinese National Human Genomecenter Specific markers for pancreatic cancer
CN1726395A (zh) * 2002-12-17 2006-01-25 北京诺赛基因组研究中心有限公司 胰腺癌的特异标记
JP2007051880A (ja) * 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
KR20090003308A (ko) * 2006-03-02 2009-01-09 온코세라피 사이언스 가부시키가이샤 Ｒｅｇ４ 단백질을 이용한 췌장암 진단 방법
DK2140269T3 (da) * 2007-03-27 2013-12-16 Immunovia Ab Proteinsignatur/markører til at detektere adenocarcinom
CA2731438C (en) * 2008-08-08 2017-07-11 Immunomedics, Inc. Anti-pancreatic cancer antibodies
SG10201710447QA (en) * 2010-08-13 2018-02-27 Somalogic Inc Pancreatic cancer biomarkers and uses thereof
GB201103726D0 (en) * 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
TWI408370B (zh) * 2011-05-19 2013-09-11 Univ Chang Gung 胰臟癌之血清生物檢測標誌及其應用
KR101358510B1 (ko) * 2011-09-28 2014-02-06 사회복지법인 삼성생명공익재단 카텝신 ｄ와 매트릭스 메탈로프로틴나제-7의 측정수단을 포함하는 췌장암 진단용 키트
KR101384211B1 (ko) * 2012-03-19 2014-04-14 서울대학교산학협력단 췌장암 진단용 마커 및 이의 용도
JP2014020930A (ja) * 2012-07-18 2014-02-03 Kanazawa Univ 膵癌診断及び治療効果予測判定バイオマーカー

Also Published As

Publication number Publication date
CN106461665B (zh) 2019-01-25
CN106461665A (zh) 2017-02-22
JP2017526896A (ja) 2017-09-14
KR20150129932A (ko) 2015-11-23
WO2015174585A1 (ko) 2015-11-19
PL3144676T3 (pl) 2020-07-13
EP3144676A1 (en) 2017-03-22
US10656154B2 (en) 2020-05-19
EP3144676A4 (en) 2017-09-27
JP6361943B2 (ja) 2018-07-25
ES2776733T3 (es) 2020-07-31
CN106461665A8 (zh) 2017-06-30
PT3144676T (pt) 2020-03-23
EP3144676B1 (en) 2019-12-11
US20170153239A1 (en) 2017-06-01

Similar Documents

Publication Publication Date Title
DK3458479T3 (da) Anti-b7-h3-antistoffer og antistof-lægemiddelkonjugater
DK3182999T3 (da) Anti-lag3-antistoffer og antigenbindingsfragmenter
DK3443009T3 (da) Anti-tim-3-antistoffer og sammensætninger
DK3307274T3 (da) Anti-cd123-antistoffer og konjugater deraf
DK3370768T3 (da) Antistoffer som specifikt binder pd-1 og anvendelser deraf
DK3455257T3 (da) Anti-pd-l1-antistoffer
KR102355950B9 (ko) Tigit에 대한 항체
DK3332006T5 (da) Hidtil ukendte anti-PD-L1-antistoffer
DK3353212T3 (da) Optimerede bispecifikke anti-CD3-antistoffer og anvendelser deraf
DK3333192T3 (da) Antistof imod glypican-3 og anvendelse deraf
DK3350220T3 (da) Anti-pro/latente-myostatin-antistoffer og anvendelser deraf
CL2016001646A1 (es) Anticuerpos y fragmentos anti-vista
DK3274370T3 (da) Anti-ceacam6-antistoffer og anvendelser deraf
DK3313884T3 (da) Anti-cd123-antistoffer og konjugater og derivater deraf
DK3344654T3 (da) Anti-lag-3-antistoffer
DK3309174T3 (da) ANTI-PD-L1-antistoffer og diagnostiske anvendelser deraf
DK3508502T3 (da) Kombination af anti-lag-3-antistoffer og anti-pd-1-antistoffer til behandling af tumorer
DK3316909T3 (da) Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder
DK3242892T3 (da) Modificerede april-bindende antistoffer
DK3134127T3 (da) Antistoflægemiddelkonjugater med høj lægemiddelladning
DK3463435T3 (da) Alpha-synuklein-antistoffer og anvendelser deraf
DK3126388T3 (da) Anti-EGFRvIII-antistoffer og anvendelser deraf
DK2970460T3 (da) Anti-IL-33-antistoffer og anvendelser deraf
DK3026062T3 (da) Anti-pd-1-antistof og anvendelse deraf
DK2953976T3 (da) Specifikke modificeringssteder i antistoffer til fremstilling af immunkonjugater